Sumura M, Ogawa K, Nagami T, Anjiki H, Koike C, Arichi N, Mitsui Y, Nakamura S, Hiraoka T, Yasumoto H, Hara S, Yoshizako T, Shiina H:Results of Targeted Biopsy with Real-time balloon inflation elastography of Prostate. AUA 2015(American Urological Association) Annual Meeting New Orleans, LA, USA May 15-19 2015
Mitsui Y, Arichi N, Hiraki M, Yasumoto H, Fukuhara S, Chang I, Hirata H, Yamamura S, Shahryari V, Deng G, Lan R, Saini S, Majid S, Dahiya R, Tanaka Y, Shiina H: Candidate biomarker for bone morphogenetic protein 2 predicts renal cell carcinoma progression via its promoter CpG hypermethylation.AUA 2015(American Urological Association) Annual Meeting New Orleans, LA, USA May 15-19 2015
Mitsui Y, Chang I, Arichi N, Hiraki M, Yasumoto H, Fukuhara S, Hirata H, Yamamura S, Shahryari V, Deng G, Lan R, Saini S, Majid S, Shiina H, Dahiya R, Tanaka Y:Attractive strategy for treatment of advanced renal cell carcinoma based on versican expression. AUA 2015(The 110th American Urological Association) Annual Meeting New Orleans, LA, USA May 15-19 2015
Arichi N, Ogawa K, Nagami T, Mitsui Y, Nakamura S, Yasumoto H and Shiina H:FIRST REPORT OF RENSL FAILURE CAUSED BY UPSHAW-SCHULMAN SYNDROME SUCCESSFULLY TREATED WITH KIDNEY TRANSPLANTATION.European Society for Organ Transplantation(ESOT) Brussels,Belgium 13-16 Sep 2015
Arichi N, Sumura M, Ogawa K, Nagami T, Anjiki T, Koike C, Nakamura S, Mitsui Y, Hiraoka T, Yasumoto H, Shiina H:Functional imaging by MAS with 1.5T MR device with phased array external surface coil can determine the prostate cancer foci.第103回日本泌尿器科学会総会 金沢 2015.4
Arichi N, Sumura M, Hiraki M, Nakamura S, Yasumoto H, Shiina H : Prostate cancer prediction by1.5T MR-spectrometry with phased array external surface coil第67回西日本泌尿器科学会総会 福岡市 2015.11
Arichi N, Hiraki M, Nakamura S, Sumura M, Yasumoto H, Shiina H : Diminished anti-tumor activity of zoledronic acid when combined with docetaxel in bladder cancer cell lines第67回西日本泌尿器科学会総会 福岡市 2015.11
Nakamura T, Yoshizako T, Araki H, Maruyama M, Uchida K, Tamaki Y, Ishikawa N, Shiina H, Kitagaki H: The relation between apparent diffusion coefficient and clinical stage of clear-cell renal cell carcinoma. Clin Imaging. 2015 Jan-Feb;39(1):72-5.
Maruyama M, Yoshizako T, Uchida K, Araki H, Tamaki Y, Ishikawa N, Shiina H, Kitagaki H: Comparison of utility of tumor size and apparent diffusion coefficient for differentiation of low- and high-grade clear-cell renal cell carcinoma. Acta Radiol. 2015 Feb;56(2):250-6.
Arichi N, Mitsui Y, Hiraki M, Nakamura S, Hiraoka T, Sumura M, Hirata H, Tanaka Y, Dahiya R, Yasumoto H, Shiina H: Versican is a potential therapeutic target in docetaxel-resistant prostate cancer. Oncoscience. 2015 Mar 2;2(2):193-204.
Mitsui Y, Hirata H, Arichi N, Hiraki M, Yasumoto H, Chang I, Fukuhara S, Yamamura S, Shahryari V, Deng G, Saini S, Majid S, Dahiya R, Tanaka Y, Shiina H :Inactivation of bone morphogenetic protein 2 may predict clinical outcome and poor overall survival for renal cell carcinoma through epigenetic pathways. Oncotarget. 2015 Apr 20;6(11):9577-91.
Fukuhara S, Chang I, Mitsui Y, Chiyomaru T, Yamamura S, Majid S, Saini S, Deng G, Gill A, Wong DK, Shiina H, Nonomura N, Lau YF, Dahiya R, Tanaka Y:Functional role of DNA mismatch repair gene PMS2 in prostate cancer cells. Oncotarget. 2015 Jun 30;6(18):16341-51.
Mitsui Y, Arichi N, Hiraki M, Harada Y, Yasumoto H, Shiina H:Tissue Chromogranin A Expression during Prostate Cancer Progression: Prediction of Chemosensitivity. Urology Journal.2015 Jul 1;12(3):2165-72
Mitsui Y, Chang I, Fukuhara S, Hiraki M, Arichi N, Yasumoto H, Hirata H, Yamamura S, Shahryari V, Deng G, Wong DK, Majid S, Shiina H, Dahiya R, Tanaka Y.: CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinoma. BMC Cancer. 2015 Dec 1;15(1):942.
安食 春輝, 有地 直子, 中村 成伸, 三井 要造, 洲村 正裕, 安本 博晃, 椎名 浩昭, 宇野 千恵, 原田 裕治:下大静脈に達する腫瘍塞栓を合併した小径腎血管筋脂肪腫の1例(TUMOR THROMBUS EXTENDING INTO THE INFERIOR VENA CAVA IN A CASE OF SMALL ANGIOMYOLIPOMA IN THE KIDNEY)(英語) 西日本泌尿器科 77巻1号 Page22-28 2015.01